Respiro-pro Liquid
NDC Package 71742-0010-1
Package Information
Respiro-pro (ammonium muriaticum, antimonium tartaricum, arsenicum album, bryonia (alba), calcarea carbonica, lobelia inflata, natrum sulphuricum, phosphorus, spongia tosta) liquids May temporarily relieve symptoms due to chronic lung disorders, lung inflammation. This formulation utilizes a liquid delivery system. Marketed by Guangzhou Renuma Medical Systems Co., Ltd, this product is identified by NDC 71742-0010.
Identification & Billing
Clinical Specifications
- AMMONIUM CHLORIDE 30 [hp_X]/mL
- ANTIMONY POTASSIUM TARTRATE 30 [hp_X]/mL
- ARSENIC TRIOXIDE 30 [hp_X]/mL
- BRYONIA ALBA ROOT 30 [hp_X]/mL
- LOBELIA INFLATA 30 [hp_X]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 30 [hp_X]/mL
- PHOSPHORUS 30 [hp_X]/mL
- SODIUM SULFATE 30 [hp_X]/mL
- SPONGIA OFFICINALIS SKELETON, ROASTED 30 [hp_X]/mL
Regulatory & Marketing
Hierarchy Structure
- 71742 - Guangzhou Renuma Medical Systems Co., Ltd
- 71742-0010 - Respiro-pro
- 71742-0010-1 - 59 mL in 1 BOTTLE, DROPPER
- 71742-0010 - Respiro-pro
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71742-0010-1 identifies a specific commercial package of 59 ml in 1 bottle, dropper of Respiro-pro T016, a human over the counter drug labeled by Guangzhou Renuma Medical Systems Co., Ltd. This liquid is formulated for oral use and contains ammonium chloride; antimony potassium tartrate; arsenic trioxide; bryonia alba root; lobelia inflata; oyster shell calcium carbonate, crude; phosphorus; sodium sulfate; spongia officinalis skeleton, roasted as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangzhou Renuma Medical Systems Co., Ltd on October 26, 2017. The current certification is valid through December 31, 2026.
How is this Guangzhou Renuma Medical Systems Co., Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71742001001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.